2018³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(8/24) : 2018-08-24±³À°ÀÏÀÚ : 2018-08-24
±³À°Àå¼Ò : ¼¿ï µå·¡°ï½ÃƼ 5Ãþ ¹éµÎȦ
±³À°ÁÖÁ¦ :
2018³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(8/24) ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320
À̸ÞÀÏ :
office@thyroid.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 450¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 4 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í *Àü¹®ÀÇ/ÀϹÝÀÇ - Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ): »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø - ºñȸ¿ø: »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø *Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ - Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ): »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø - ºñȸ¿ø: »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø *¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø: ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 13:00~13:05 °³È¸½Ä ¹× Çмú´ëȸ ÇÁ·Î±×·¥ ¼Ò°³ ()
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 13:05~13:25 Introduction: Thyroid Hormone, Lipid and Glucose Metabolism ±è¹ÎÈñ(°¡Åç릑ÀÇ´ë ³»°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 13:25~13:45 Metabolic and Cardiovascular Risk in Thyroid Disease ±èÁøÈ(Á¶¼±ÀÇ´ë ³»°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 13:45~14:05 How to manage metabolic syndrome in thyroid disease: diabetes and dyslipidemia ÀÌÁÖÈñ(Ãæ³²ÀÇ´ë ³»°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 14:05~14:35 ¿¬¸íÀÇ·á°áÁ¤¹ýÀ̶õ? °í¼öÁø(¿ï»êÀÇ´ë Ç÷¾×Á¾¾ç³»°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 14:35~14:45 »çÀü¿¬¸íÀÇ·áÀÇÇâ¼¿Í ¿¬¸íÀÇ·á°èȹ¼ À̸í¾Æ(°¡Å縯ÀÇ´ë Á¾¾ç³»°ú)
ÈÞ½Ä 08¿ù 24ÀÏ ¹éµÎȦ 1+2 15:05~15:35 Coffee Break ()
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 15:35~15:50 Changes in the Initial Surgical Treatment ¹ÚÁø¿ì(ÃæºÏÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 15:50~16:05 The Role of Active Surveillance as a Realistic Option ¼Û¿µ±â(¿ï»êÀÇ´ë ³»°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 16:05~16:20 The Role of Pathology Reports and Molecular Analysis for Surgical Decision Making ±èÈñ¼º(Áß¾ÓÀÇ´ë º´¸®°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 16:20~16:35 The Role of Stimulated Thyroglobulin Testing for Therapeutic Decisions õ±âÁ¤(¼¿ïÀÇ´ë ÇÙÀÇÇаú)
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 1+2 16:50~17:50 Radioiodine Therapy in Metastatic/Residual Thyroid Cancer Á¤Áرâ(¼¿ïÀÇ´ë ÇÙÀÇÇаú)
±âŸ 08¿ù 24ÀÏ ¹éµÎȦ 3 13:05~14:05 Free Paper 1 ()
±âŸ 08¿ù 24ÀÏ ¹éµÎȦ 3 14:05~15:05 Free Paper 2 ()
ÈÞ½Ä 08¿ù 24ÀÏ ¹éµÎȦ 3 15:05~15:35 Coffee Break ()
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 3 16:50~17:10 Nodal Management °°æÈ£(Áß¾ÓÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 3 17:10~17:30 Trachea, Esophagus Invasion Management À̱¹Çà(¿øÀڷº´¿ø À̺ñÀÎÈÄ°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ¹éµÎȦ 3 17:30~17:50 Mediastinal Lesion Management ÀåÇ×¼®(¿¬¼¼ÀÇ´ë ¿Ü°ú)